A recent study has revealed that women undergoing in vitro fertilization (IVF) or intrauterine insemination (IUI) face higher maternal morbidity risks compared to those who conceive without medical assistance.
Dr. Alina Pelikh, a senior research fellow in demography and deputy research director at the Centre for Longitudinal Studies, University College London, and her team emphasized the importance of public health initiatives aimed at promoting elective single embryo transfer. They suggested that counseling on the risks of maternal morbidity, particularly in medically assisted reproduction-related multifetal pregnancies, could help guide safer treatment decisions. This, in turn, could potentially reduce maternal health risks and related healthcare costs.
In another prominent update in women’s health, Healio reported an expert presentation at The Pregnancy Meeting, where new findings were shared regarding an RNA platform. The platform, which analyzes millions of maternal, fetal, and placental RNA messages, could help predict pregnancy complications, offering potential advancements in prenatal care.
Related topics:
Discontinuing Antidepressants During Pregnancy May Lower Risk of PPHN, Study Finds
Air Pollution Before Pregnancy Linked to Increased Risk of Childhood Obesity, Study Finds
Assessing the Validity and Predictive Power of the WHO-5 Index in Pregnant Women
